Rheumatic Joint Disease clinical trials at UCSF

1 research study open to eligible people

Rheumatic joint disease causes swelling and pain in the joints. UCSF is collecting data on children with these diseases to understand them better. This study helps track how the diseases progress over time.

Showing trials for

  • Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

    open to eligible people ages up to 21 years

    Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

    San Francisco, California and other locations

Our lead scientists for Rheumatic Joint Disease research studies include .

Last updated: